Immunohistochemistry analysis of Pygo2 expression in central nervous system tumors
Pygo2 as a Wnt signaling pathway component has been detected in multiple cancer types. In this study, we identified Pygo2 expression features by immunohistochemistry in 73 central nervous system tumor specimens, in comparison with 14 normal brain tissues and surrounding non-tumorous tissues of tumor. Our study indicated that 59% of the patient tumor specimens exhibited positive Pygo2-staining and increases intensity with the grade of malignancy, especially for WHO grade III and IV gliomas, was observed high level expression, compared with normal brain tissues. Five out of nine WHO grade III anaplastic astrocytomas and seven out of nine WHO grade IV glioblastomas showed Pygo2-positive staining. The analysis of Pygo2 gene expression by quantitative real-time PCR of additional ten fresh patient samples yielded similar results. Further studies performed with stable cell lines in vitro demonstrated that Pygo2 render cells higher proliferation rate, migration and anchorage-independent colony-forming ability in soft agar. Taken together, our studies suggest an important role of Pygo2 in brain tumor progression.
KeywordsPygo2 Gliomas Immunohistochemistry Glioblastomas
T cell factor
Lymphoid enhancer binding factor
- PHD finger
Plant homeodomain finger
This research was supported by The National Natural Science Foundation of China (Grant No. 31501126). We thank Chao Ma, Heng Wei, and Feng Chen for supplying samples and medical assistance.
- Andrews PG, Lake BB, Popadiuk C, Kao KR (2007) Requirement of Pygopus 2 in breast cancer. Int J Oncol 30:357–363Google Scholar